Multidisciplinary board members bring expertise in drug discovery, clinical development, computational life science, GPCRs and drug formulationBOSTON, Sept. 30, 2024…
– Company is aligned with the FDA on next steps for a 351(k) regulatory pathway to approval for ABP-450 (prabotulinumtoxinA)…
Company to leverage capital and Valor’s expertise for strategic initiatives building market awareness, R&D roadmap, data analysis capabilities, and expanding…
Conference presentation delivers preclinical results demonstrating Ketamir-2 achieves 100% reversal of neuropathic painMIAMI, FL / ACCESSWIRE / September 27, 2024…
PUERTO DE SANTA MARIA, Spain, Sept. 26, 2024 /PRNewswire/ -- In his book, Contact with the Future: The Astonishing Power of…
MINNEAPOLIS , Sept. 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore,…
ORLANDO, Fla., Sept. 25, 2024 /PRNewswire/ -- The American Institute of Ultrasound in Medicine (AIUM) is excited to announce the…
Chief Strategy Officer Dr. John Showalter will also explain during FMX Med Talk why early detection of cognitive impairment by…
GALWAY, Ireland and CHICAGO, Sept. 25, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced…
Lille, September 25, 2024 - InBrain Pharma, a biopharmaceutical company specialized in neurodegenerative diseases, will present the positive results of its…